Omental fat receptor interacting protein 140 mRNA expression in women with polycystic ovary syndrome

Gynecologic and Obstetric Investigation

Volumn 69, Issue 1, 2010, Pages 51-56

  Seow, Kok Min ^a,b   Tsai, Yieh Loong ^a,b   Juan, Chi Chang ^c,d,e   Huang, Lee Wen ^a,b   Hwang, Jiann Loung ^a,f   Ho, Low Tone ^e  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adipose tissue; Laparoscopic ovarian electrocauterization; Polycystic ovary syndrome; Receptor interacting protein 140

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; RECEPTOR INTERACTING PROTEIN 140;

ADIPOSE TISSUE; ADULT; ANOVULATION; ARTICLE; BODY MASS; CAUTERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LAPAROSCOPIC SURGERY; LEAN BODY WEIGHT; METABOLIC PARAMETERS; OBESITY; OMENTUM; OVARY POLYCYSTIC DISEASE; OVULATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; LAPAROSCOPY; LUTEINIZING HORMONE; NUCLEAR PROTEINS; OVULATION; POLYCYSTIC OVARY SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE;

EID: 70350542695     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253852     Document Type: Article

References (28)

1. Lee CH, Chinpaisal C, Wei LN: Cloning and characterization of mouse RIP140, a co-repressor for nuclear orphan receptor TR2. Mol Cell Biol 1998; 18: 6745-6755.
2. Leonardsson G, Jacobs MA, White R, Jeffery R, Poulsom R, Milligan S, Parker M: Embryo transfer experiments and ovarian transplantation identify the ovary as the only site in which nuclear receptor interacting protein 1/RIP140 action is crucial for female fertility. Endocrinology 2002; 143: 700-707.
3. Parker M, Leonardsson G, White R, Steel J, Milligan S: Identification of RIP140 as a nuclear receptor cofactor with a role in female reproduction. FEBS Lett 2003; 546: 149-153.
4. White R, Leonardsson G, Rosewell I, Ann Jacobs M, Milligan S, Parker M: The nuclear receptor co-repressor NRIP (RIP140) is essential for female fertility. Nat Med 2000; 6: 1368-1374.
5. Donnez J, Thomas K: Incidence of the luteinized unruptured follicle syndrome in fertile women and women with endometriosis. Eur J Obstet Gynecol Biol 1982; 14: 187-190.
6. Koninckx PR, De Moor P, Brosens IA: Diagnosis of the luteinized unruptured follicle syndrome by steroid hormone assays on peritoneal fluid. Br J Obstet Gynaecol 1980; 87: 929-934.
7. Steel JH, White R, Parker MG: Role of the RIP140 co-repressor in ovulation and adipose biology. J Endocrinol 2005; 185: 1-9.
8. Leonardsson G, Steel JH, Christian M, Pocock V, Milligan S, Bell J, So PW, Medina- Gomez G, Vidal-Puig A, White R, Parker MG: Nuclear receptor co-repressor RIP140 regulates fat accumulation. Proc Natl Acad Sci USA 2004; 101: 8437-8442.
9. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Hum Reprod 2004; 19: 41-47.
10. Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800.
11. Dunaif A: Polycystic ovary syndrome and obesity; in Bjorntorp P, Brodoff BN (eds): Obesity. Philadelphia, Lippincott, 1992, pp 594-605.
12. Li TC, Saravelos H, Chow MS, Chisabingo R, Cooke ID: Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovary syndrome in women with anovulatory infertility. Br J Obstet Gynecol 1998; 105: 338-344.
13. Stein IF, Leventhal ML: Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191.
14. Seow KM, Juan CC, Hwang JL, Low TL: Laparoscopic surgery in PCOS: reproductive and metabolic effects. Semin Reprod Med 2008; 26: 101-110.
15. Christian M, Kiskinis E, Debevec D, Leonardsson G, White R, Parker MG: RIP140- targeted repression of gene expression in adipocytes. Mol Cell Biol 2005; 25: 9383-9391.
16. Legro RS, Finegood D, Dunaif A: A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-2698.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. Kauffman RP, Baker VM, Dimarino P, Gimpel T, Castracane VD: Polycystic ovarian syndrome and insulin resistance in white and Mexican-American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002; 187: 1362-1369.
19. Legro RS, Kunselman AR, Dodson WC, Dunaif A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165-169.
20. Seow KM, Juan CC, Ho LT, Hsu YP, Lin YH, Huang LW, Hwang JL: Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome. Hum Reprod 2007; 22: 1100-1106.
21. Tredway DR, Warne DW, Eshkol A, Alam V: Correlation between luteal serum progesterone levels and pregnancy in ovulation induction. Fertil Steril 2007; 88:S195.
22. Westhoff C, Schafer J, Morroni C, Herman S, Osborne L: Ovulation in the first cycle of immediate start of the monthly vaginal ring for birth control and a triphasic oral contraceptive. Fertil Steril 2004; 82:S107.
23. Rodbell M: Metabolism of isolated fat cell. I. Effects of hormone on glucose metabolism and lipolysis. J Biol Chem 1964; 239: 375-380.
24. Chang RJ: The reproductive phenotype in polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007; 10: 688-695.
25. Burghen GA, Givens, JR, Kitabchi, AE: Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50: 113-116.
26. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141-146.
27. Ciaraldi TP, Morales AJ, Hickman MG, Odom-Ford R, Olefsky JM, Yen SS: Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J Clin Endocrinol Metab 1997; 82: 1421-1425.
28. Corton M, Botella-Carretero JI, Benguria A, Villeundas G, Zaballos A, San Millán JL, Escobar- Morreale HF, Peral B: Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 328-337.